High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (≥65 years) myeloma patients : comparison with younger patients treated on the same protocol
2006
High-dose melphalan (200 mg/m 2 ) supported by autologous stem cell transplantation is safe and effective in elderly (65 years) myeloma patients: comparison with younger patients treated on the same protocol
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
79
Citations
NaN
KQI